References
- Yuan X, Desiderio DM. Proteomics analysis of human cerebrospinal fluid. J Chromatogr Analyt Technol Biomed Life Sci 2005;815:179–89.
- Davidsson P, Ekman R, Blenov K. A new procedure for detecting brain-specific proteins in cerebrospinal fluid. J Neural Transm 1997;104:711–20.
- D’Aguano S, Del Boccio P, Bernardini S, Ballone E, Di Ilio C, Federici G, Urbani A. Electrophoretic separations of cerebrospinal fluid proteins in clinical investigation. Clin Chem Lab Med 2007;45:437–49.
- Gallo P, Bracco F, Morara S, Battistin L, Tavaloto B. The cerebrospinal fluid transferrin/tau proteins. A study by two-dimensional polyacrylamide gel electrophoresis (2D) and agarose isoelectrofocusing (IEF) followed by double-antibody peroxidase labeling and avidin-biotin amplification. J Neurol Sci 1985;70:81–92.
- Vanderver A, Schiffmann R, Timmos M, Kellersberger KA, Fabris D, Hoffman EP, Maletkovic J, Hathout Y. Decreased asialotransferrin in cerebrospinal fluid of patients with childhood-onset ataxia and central nervous system hypomyelination/vanishing white matter disease. Clin Chem 51;2005: 2031–42.
- Schiffmann R, Elroi-Stein O. Childhood ataxia with CNS hypomyelination/vanishing white matter disease – A common leukodystrophy caused by abnormal control of protein synthesis. Mol Genet Metab 2006;88:7–15.
- Vanderver A, Hathout Y, Maletkovic J, Gordon ES, Mintz M, Hoffman EP, Horzinski L, Niel F, Fogli A, BoespfugTanguy O, Schiffmann R. Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder. Neurology 2008;70:2226–32.
- Mochel F, Sedel F, Vanderver A, Engelke UF, Barritault J, Yang BZ, Kulkarni B, Adams DR, Clot F, Ding JH, Kaneski CR, Verheijen FW, Smits BW, Seguin F, Brice A, Vanier MT, Huizing M, Schiffmann R, Durr A, Wevers RA. Cerebellar ataxia with elevated cerebrospinal free sialic acid (CAFSA). Brain 2009;132:801–9.
- Sinha A, Srivastava N, Singh S, Singh AK, Bhushan S, Shukla R, Singh MP. Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach. Clin Chim Acta 2009;400: 14–20.
- Taniguchi M, Okayama Y, Hashimoto Y, Kitaura M, Jimbo D, Wakunati Y, Wada-Isoe K, Nakashima K, Akatsu H, Furukawa K, Arai H, Urakami K. Sugar chains of cerebrospinal fluid transferrin as a new biological marker of Alzheimer's disease. Dement Geriatr Cogn Disord 2008;26:117–22.
- Liebler DC. Introduction to proteomics: tools for the new biology. Totowa: Humana Press; 2002.
- Hillenkamp F, Katalinic JP. MALDI MS: a practical guide to instrumentation, methods and applications. Weinheim: Wiley-VCH; 2007.
- Sanders EL, Clark RJ, Katzmann JA. Cerebrospinal fluid leakage:agarose gel electrophoresis detection of β2-transferrin and nephelometric quantification of β2- trace protein. Clin Chem 2004;50:2401–3.